To Preserve or Not to Preserve the Orbit in Paranasal Sinus Neoplasms: A Meta-Analysis

 

 Permissions and Reprints

Abstract

Context The effect on survival of orbital evisceration on patients with paranasal sinus neoplasms has not been well established.

Objective To review systematically the available literature concerning survival in patients who undergo surgery for paranasal sinus neoplasm with and without preservation of the eye.

Data Source A retrospective meta-analysis of English and non-English articles using Medline and the Cochrane database.

Eligibility Criteria Studies analyzing 5-year survival rates in patients who had orbital evisceration compared with orbital preservation for the treatment of paranasal sinus neoplasms were included in the final analysis.

Data Extraction Independent review by two authors using predefined data fields.

Data Synthesis A meta-analysis of four articles involving 443 patients was performed using the DerSimonian-Laird random-effects method.

Results Our analysis revealed a total effect size of 0.964 in favor of preservation of the eye; however, these results are not robust, having a true effect size anywhere from 0.785 to 1.142 with a 95% confidence interval.

Limitations Only retrospective observational studies were included because a prospective randomized study cannot be performed in this population.

Conclusion Our study supports the notion that in select patients preservation of the eye may yield a different outcome when compared with orbital evisceration.

• References

• 1 Haerle SK, Gullane PJ, Witterick IJ, Zweifel C, Gentili F. Sinonasal carcinomas: epidemiology, pathology, and management. Neurosurg Clin N Am 2013; 24 (1) 39-49
  CrossrefPubMedGoogle Scholar
• 2 Suarez C, Llorente JL, Fernandez De Leon R, Maseda E, Lopez A. Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 2004; 26 (2) 136-144
  CrossrefPubMedGoogle Scholar
• 3 Sheskin DJ. Handbook of Parametric and Nonparametric Statistical Procedures. 5th ed. Boca Raton, FL: Chapman & Hall/CRC Taylor & Francis Group; 2011
  CrossrefGoogle Scholar
• 4 Stern SJ, Goepfert H, Clayman G, Byers R, Wolf P. Orbital preservation in maxillectomy. Otolaryngol Head Neck Surg 1993; 109 (1) 111-115
  PubMedGoogle Scholar
• 5 Shah JP, Kraus DH, Bilsky MH, Gutin PH, Harrison LH, Strong EW. Craniofacial resection for malignant tumors involving the anterior skull base. Arch Otolaryngol Head Neck Surg 1997; 123 (12) 1312-1317
  CrossrefPubMedGoogle Scholar
• 6 Nishino H, Ichimura K, Tanaka H , et al. Results of orbital preservation for advanced malignant maxillary sinus tumors. Laryngoscope 2003; 113 (6) 1064-1069
  CrossrefPubMedGoogle Scholar
• 7 Essig GF, Newman SA, Levine PA. Sparing the eye in craniofacial surgery for superior nasal vault malignant neoplasms: analysis of benefit. Arch Facial Plast Surg 2007; 9 (6) 406-411
  CrossrefPubMedGoogle Scholar
• 8 Rajapurkar M, Thankappan K, Sampathirao LMCS, Kuriakose MA, Iyer S. Oncologic and functional outcome of the preserved eye in malignant sinonasal tumors. Head Neck 2013; 35 (10) 1379-1384
  PubMedGoogle Scholar
• 9 McCary WS, Levine PA, Cantrell RW. Preservation of the eye in the treatment of sinonasal malignant neoplasms with orbital involvement. A confirmation of the original treatise. Arch Otolaryngol Head Neck Surg 1996; 122 (6) 657-659
  CrossrefPubMedGoogle Scholar
• 10 Nazar G, Rodrigo JP, Llorente JL, Baragaño L, Suárez C. Prognostic factors of maxillary sinus malignancies. Am J Rhinol 2004; 18 (4) 233-238
  CrossrefPubMedGoogle Scholar
• 11 Howard DJ, Lund VJ, Wei WI. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses: a 25-year experience. Head Neck 2006; 28 (10) 867-873
  CrossrefPubMedGoogle Scholar
• 12 Kuo C-H, Gao K, Clifford A, Shannon K, Clark J. Orbital exenterations: an 18-year experience from a single head and neck unit. ANZ J Surg 2011; 81 (5) 326-330
  CrossrefPubMedGoogle Scholar
• 13 Tiwari R, van der Wal J, van der Waal I, Snow G. Studies of the anatomy and pathology of the orbit in carcinoma of the maxillary sinus and their impact on preservation of the eye in maxillectomy. Head Neck 1998; 20 (3) 193-196
  CrossrefPubMedGoogle Scholar
• 14 Papadimitrakopoulou VA, Ginsberg LE, Garden AS , et al. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma. Cancer 2003; 98 (10) 2214-2223
  CrossrefPubMedGoogle Scholar
• 15 Som ML. Surgical management of carcinoma of the maxilla. Arch Otolaryngol 1974; 99 (4) 270-273
  CrossrefPubMedGoogle Scholar
• 16 Perry C, Levine PA, Williamson BR, Cantrell RW. Preservation of the eye in paranasal sinus cancer surgery. Arch Otolaryngol Head Neck Surg 1988; 114 (6) 632-634
  CrossrefPubMedGoogle Scholar
• 17 Wu X, Tang P, Qi Y. Management of the orbital contents in radical surgery for squamous cell carcinoma of the maxillary sinus. Chin Med J (Engl) 1995; 108 (2) 123-125
  PubMedGoogle Scholar
• 18 Iannetti G, Valentini V, Rinna C, Ventucci E, Marianetti TM. Ethmoido-orbital tumors: our experience. J Craniofac Surg 2005; 16 (6) 1085-1091
  CrossrefPubMedGoogle Scholar
• 19 Lund VJ, Howard DJ, Wei WI, Cheesman AD. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses—a 17-year experience. Head Neck 1998; 20 (2) 97-105
  CrossrefPubMedGoogle Scholar
• 20 Imola MJ, Schramm Jr VL. Orbital preservation in surgical management of sinonasal malignancy. Laryngoscope 2002; 112 (8 Pt 1) 1357-1365
  CrossrefPubMedGoogle Scholar
• 21 Carrau RL, Segas J, Nuss DW , et al. Squamous cell carcinoma of the sinonasal tract invading the orbit. Laryngoscope 1999; 109 (2 Pt 1) 230-235
  CrossrefPubMedGoogle Scholar